Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin for Renal Protection in RALPN
NCT02258906Completed
- Sponsor
- Yonsei University
- Start
- Oct 2014
- Primary completion
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of ulinastatin in renal mass, sponsored by Yonsei University. Primary endpoints: serum creatinine at 3 days and cystatin C at 3 days. Started Oct 2014; status: completed.
02
Drugs
ulinastatin
03
Conditions
renal mass
Beyond the preview
Go deeper on NCT02258906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02258906.